Home / Companies / Labcorp Drug Development Covance / Trends
Labcorp Drug Development Covance H-1B trends
Quarterly LCA aggregate trend points for Labcorp Drug Development Covance. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Labcorp Drug Development Covance span 2021 Q3 to 2021 Q4, peaking at 1 filings in 2021 Q3.
The most recent reported period (2021 Q4) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2021 Q3 | 1 | 1 | 1 | $131,000 | $124,051 | 1 | 100.0% |
| 2021 Q4 | 1 | 1 | 1 | $150,000 | $133,266 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Labcorp Drug Development Covance changed over time?
- H-1B LCA filings for Labcorp Drug Development Covance span 2021 Q3 to 2021 Q4, peaking at 1 filings in 2021 Q3. The most recent reported period (2021 Q4) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=labcorp+drug+development+covance&metric=lca_countJSON